申请人:Merck Sharp & Dohme Corp.
公开号:US20150329557A1
公开(公告)日:2015-11-19
The present invention provides compounds of Formula I
and the pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and conditions associated with excessive salt and water retention.
本发明提供了I式化合物及其药学上可接受的盐,它们是ROMK(Kir1.1)通道的抑制剂。这些化合物可用作利尿剂和/或钠利尿剂,并用于治疗和预防包括高血压、心力衰竭和与过度盐和水潴留有关的医疗条件在内的心血管疾病。